FDA Seeks Outcomes Data For Merck’s MK-0524A
The wait for cardiovascular trial’s finish will push back refiling for the niacin/laropiprant combo to 2013.
The wait for cardiovascular trial’s finish will push back refiling for the niacin/laropiprant combo to 2013.